EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

2 hedge funds and large institutions have $12.1K invested in Eagle Pharmaceuticals, Inc. in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$11.8K
2
-$9K
3
-$7K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3K
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.71K
Name Holding Trade Value Shares
Change 		Change in
Stake
SLG
1
Stanley-Laman Group
Pennsylvania
$11.8K
AIC
2
Archer Investment Corporation
Indiana
$343
XT
3
XTX Topco
Cayman Islands
–
Simplex Trading
4
Simplex Trading
Illinois
–
Barclays
5
Barclays
United Kingdom
–
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
–
Russell Investments Group
7
Russell Investments Group
United Kingdom
–
Credit Agricole
8
Credit Agricole
France
–
FFA
9
Farther Finance Advisors
California
–